THE ROLE OF EGFR AND FOXG1 IN DIFFUSE MIDLINE GLIOMA RESPONSE TO MITOCHONDRIAL-TARGETING DRUGS

$896,070FY2021Defense Health AgencyDOD

Children'S Research Institute, Washington DC

Investigators